Analyst Amit Bhalla said that trade-in revenue from customers who purchase the HiSeq 2000 platform would not be a "significant contributor," and trimmed total revenue estimates for the second quarter and full-year 2011.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.